Skip to main content
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Author

IU Simon Comprehensive Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the central hub for cancer research and education across Indiana University. Over the last three decades, its far-reaching discoveries have changed the way cancer is treated around the world. The center’s recent advances in genomics, immunotherapy, bioinformatics, and other sciences are transforming knowledge about cancer prevention, screening, diagnosis and survivorship.

Showing results for IU Simon Comprehensive Cancer Center

IU cancer center receives American Cancer Society funding for research, education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support research and education programs.

IU Simon Comprehensive Cancer Center  |  Mar 27, 2023

$3.3 million grant to IU researchers aims to increase colorectal cancer screening in rural Indiana

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are addressing the low colorectal cancer screening rates in rural Indiana communities with a five-year, $3.3 million grant from the National Cancer Institute.

IU Simon Comprehensive Cancer Center  |  Mar 23, 2023

$8 million gift establishes research fund, endowed position for bile duct cancer at IU

To create a legacy for his soulmate and to honor their 42-year marriage, IU School of Medicine alumnus Kip E. Virts, MD, has made an $8 million estate gift to support bile duct cancer research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU Simon Comprehensive Cancer Center  |  Feb 13, 2023

IU Simon Comprehensive Cancer Center sponsors Indiana racing driver Jackson Lee again in 2023

For the second consecutive season, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the primary sponsor of formula car driver Jackson Lee.

IU Simon Comprehensive Cancer Center  |  Feb 09, 2023

IU cancer researcher identifies new areas in human genomes linked to skin cancer risk

INDIANAPOLIS — An Indiana University cancer researcher has identified eight new genomic regions that increase a person’s risk for skin cancer. Jiali Han, Ph.D., and colleagues discovered eight new loci—locations on a person’s genome—that are susceptible to the development of squamous cell skin cancer. Han is the Rachel Cecile Efroymson Professor in Cancer Research at […]

IU Simon Comprehensive Cancer Center  |  Feb 18, 2020

IU cancer researcher, collaborators earn $4.1 million grant from Cancer Moonshot

INDIANAPOLIS — A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute “Cancer Moonshot” grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia. The research promises to achieve more effective, better targeted and less toxic therapies for […]

IU Simon Comprehensive Cancer Center  |  May 30, 2019

Irsay gift pushes Chuckstrong Tailgate Gala past $1.8 million for cancer research

INDIANAPOLIS — On a night when Chuck Pagano returned to Indianapolis, Colts owner Jim Irsay pledged $1 million to cancer research in his former coach’s honor, helping to raise more than $1.8 million to support scientists at the Indiana University Melvin and Bren Simon Cancer Center. Colts Chief Operating Officer Pete Ward made the announcement […]

IU Simon Comprehensive Cancer Center  |  May 10, 2019

Grant helps researchers unravel role of glucose, fats in bone cancer

INDIANAPOLIS—A $1.2 million Department of Defense grant has been awarded to an Indiana University School of Medicine physician whose research explores a cascade of events that decreases quality of life and treatment responses for patients with metastatic bone cancer. Theresa Guise, MD, hopes to understand the role of the tumor-bone microenvironment on glucose metabolism and […]

IU Simon Comprehensive Cancer Center  |  Nov 27, 2018

IU researchers awarded $2.3 million to continue studies on chemotherapy-induced peripheral neuropathy

INDIANAPOLIS — Indiana University School of Medicine cancer researchers who have been working to lessen the debilitating side effects caused by chemotherapy have been awarded $2.3 million to continue their studies. Jill Fehrenbacher, PhD, and Mark Kelley, PhD, are recipients of the five-year grant (1R01CA231267) from the National Cancer Institute, which will enable them to […]

IU Simon Comprehensive Cancer Center  |  Nov 06, 2018

IU researchers enrolling women in nationwide breast imaging study

Indiana University School of Medicine radiology researchers will recruit 3,000 women to participate in TMIST, a nationwide study comparing the two most common technologies used for breast cancer screening. Tomosynthesis, also known as three-dimensional or 3-D mammography screening, will be compared with 2-D or conventional mammography in a study conducted by the National Cancer Institute […]

IU Simon Comprehensive Cancer Center  |  Oct 26, 2018